Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer

被引：0
|
作者：
Takahiro Tsushima
Shuichi Hironaka
Narikazu Boku
Nozomu Machida
Kentaro Yamazaki
Hirofumi Yasui
Keisei Taku
Akira Fukutomi
Yusuke Onozawa
机构：
[1] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[2] Chiba Cancer Center,Clinical Research Promotion Department
来源：
Gastric Cancer | 2010年 / 13卷
关键词：
S-1; Elderly; Gastric Cancer; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：245 / 250
页数：5
相关论文
共 50 条
  • [31] Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer.
    Kelly, Ronan Joseph
    Lee, Jeeyun
    Bang, Yung-Jue
    Almhanna, Khaldoun
    Murphy, Mariela A. Blum
    Catenacci, Daniel V. T.
    Chung, Hyun Cheol
    Wainberg, Zev A.
    Gibson, Michael
    Lee, Keun Wook
    Bendell, Johanna C.
    Denlinger, Crystal S.
    Brohawn, Philip Z.
    He, Peng
    McDevitt, Jennifer
    Englert, Judson
    Ku, Geoffrey Yuyat
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] EFFICACY DIFFERENCES OF S-1 MONOTHERAPY BY HISTOLOGY IN PRETREATED PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER
    Hisamatsu, Yasushi
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Ono, Akira
    Syukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
  • [33] Efficacy and tolerability of docetaxel and cisplatin plus S-1 for advanced gastric cancer
    Luo, Haiqing
    Yu, Zhonghua
    Gao, Hongfei
    Guan, Chengnong
    Xu, Meng
    JOURNAL OF BUON, 2013, 18 (01): : 154 - 161
  • [34] Safety and efficacy of S-1 treatment in elderly patients with advanced or recurrent gastric cancer: A subgroup analysis from the phase III JFMC36-0701 trial
    Nishikawa, K.
    Yoshino, S.
    Morita, S.
    Takahashi, T.
    Sakata, K.
    Nagao, J.
    Nemoto, H.
    Murakami, N.
    Hasegawa, H.
    Shimizu, R.
    Yoshikawa, T.
    Osanai, H.
    Imano, M.
    Naitoh, H.
    Tanaka, A.
    Sakamoto, J.
    Saji, S.
    Oka, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] EFFICACY AND SAFETY OF S-1 COMBINED WITH WEEKLY CISPLATIN FOR METASTATIC GASTRIC CANCER
    Murakami, T.
    Yasui, H.
    Okazaki, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 150 - 150
  • [36] Safety and efficacy of neoadjuvant chemotherapy with S-1 and oxaliplatin plus apatinib for locally advanced gastric cancer.
    Zheng, Ya'nan
    Yang, Xiao
    Ni, Zhentian
    Zhu, Zhenglun
    Xu, Wei
    Yang, Zhongyin
    Liu, Wentao
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis
    Chen, Xing
    Wan, Lifu
    He, Yao
    Zhang, Qin
    Zheng, Xiaoyuan
    MEDICINE, 2024, 103 (21) : E38272
  • [38] Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer
    Jae Ho Jeong
    Min-Hee Ryu
    Baek-Yeol Ryoo
    Sung Sook Lee
    Inkeun Park
    Sang Hong Lee
    Kab Choong Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 523 - 529
  • [39] Safety and Feasibility of Adjuvant Chemotherapy With S-1 in Korean Patients With Curatively Resected Advanced Gastric Cancer
    Jeong, J. H.
    Ryu, M. H.
    Lee, S. S.
    Ryoo, B. Y.
    Lee, S. H.
    Kim, K. C.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S465 - S465
  • [40] Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer
    Jeong, Jae Ho
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Lee, Sung Sook
    Park, Inkeun
    Lee, Sang Hong
    Kim, Kab Choong
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 523 - 529
12345